1. Home
  2. AMTX vs IVA Comparison

AMTX vs IVA Comparison

Compare AMTX & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMTX
  • IVA
  • Stock Information
  • Founded
  • AMTX 2005
  • IVA 2011
  • Country
  • AMTX United States
  • IVA France
  • Employees
  • AMTX N/A
  • IVA N/A
  • Industry
  • AMTX Major Chemicals
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMTX Industrials
  • IVA Health Care
  • Exchange
  • AMTX Nasdaq
  • IVA Nasdaq
  • Market Cap
  • AMTX 128.6M
  • IVA 117.3M
  • IPO Year
  • AMTX N/A
  • IVA 2020
  • Fundamental
  • Price
  • AMTX $2.84
  • IVA $2.16
  • Analyst Decision
  • AMTX Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • AMTX 5
  • IVA 4
  • Target Price
  • AMTX $12.95
  • IVA $13.25
  • AVG Volume (30 Days)
  • AMTX 642.7K
  • IVA 7.3K
  • Earning Date
  • AMTX 03-06-2025
  • IVA 09-25-2024
  • Dividend Yield
  • AMTX N/A
  • IVA N/A
  • EPS Growth
  • AMTX N/A
  • IVA N/A
  • EPS
  • AMTX N/A
  • IVA N/A
  • Revenue
  • AMTX $291,400,000.00
  • IVA $20,652,523.00
  • Revenue This Year
  • AMTX $64.91
  • IVA N/A
  • Revenue Next Year
  • AMTX $42.21
  • IVA $361.78
  • P/E Ratio
  • AMTX N/A
  • IVA N/A
  • Revenue Growth
  • AMTX 59.51
  • IVA N/A
  • 52 Week Low
  • AMTX $2.10
  • IVA $1.53
  • 52 Week High
  • AMTX $7.03
  • IVA $4.50
  • Technical
  • Relative Strength Index (RSI)
  • AMTX 47.22
  • IVA 38.30
  • Support Level
  • AMTX $2.56
  • IVA $2.11
  • Resistance Level
  • AMTX $2.92
  • IVA $2.24
  • Average True Range (ATR)
  • AMTX 0.20
  • IVA 0.07
  • MACD
  • AMTX 0.02
  • IVA 0.01
  • Stochastic Oscillator
  • AMTX 51.85
  • IVA 22.07

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: